Lamotrigine Cf

Lamotrigine, the active ingredient in Lamotrigine Cf, is an Anticonvulsant presented as a tablet for oral use. It treats epilepsy and bipolar disorder by stabilizing neuronal activity. GNH USA supplies Lamotrigine Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine Cf is an antiepileptic drug that modulates neuronal excitability in seizure disorders and mood stabilization in affective illness.

Epilepsy: reduces the frequency and severity of focal and generalized seizures. Bipolar disorder: helps maintain mood stability and prevents depressive episodes. Partial seizures: decreases occurrence of focal onset seizures with or without secondary generalization.

Lamotrigine may cause a range of adverse reactions, from mild to severe. Monitoring for side effects is important during therapy.

Common Side Effects: - Dizziness or light‑headedness - Headache - Nausea or vomiting - Rash or mild skin irritation - Blurred vision - Fatigue or somnolence

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., drug reaction with eosinophilia and systemic symptoms) - Hematologic abnormalities such as aplastic anemia or agranulocytosis - Hepatic dysfunction or failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

Before initiating lamotrigine therapy, clinicians should consider several safety measures.

Dose titration: increase gradually to minimise rash risk. Skin reactions: monitor regularly for any rash or hypersensitivity. Hepatic function: assess liver status in patients with hepatic impairment. Renal function: adjust dosing in severe renal disease. Pregnancy: use only when potential benefit justifies potential risk. Store at ambient temperature: keep in original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity risk.

Major Interactions (Avoid): - Valproate: markedly raises lamotrigine levels, increasing toxicity. - Carbamazepine: lowers lamotrigine concentrations, potentially reducing efficacy. - Phenobarbital: reduces lamotrigine levels, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, necessitating monitoring. - Serotonergic agents: watch for signs of serotonin syndrome. - Other antiepileptics (e.g., phenytoin, primidone): may require dose modifications.